Skip to main content
NCBI home page
Annals of The Royal College of Surgeons of England logoLink to Annals of The Royal College of Surgeons of England
. 1993 Jan;75(1):13–17.

Management of screen-detected breast cancer: audit of the first 100 cases in the Southampton and Salisbury breast screening programme.

I Campbell 1, G Royle 1, R Coddington 1, A Herbert 1, C Rubin 1, I Taylor 1, P Guyer 1
PMCID: PMC2497746  PMID: 8422137

Abstract

With the natural history and optimal treatment of a high proportion of screen-detected breast cancers yet to be determined, treatment poses the management team with a number of therapeutic dilemmas. This study surveys the management policy and treatment of a consecutive series of 100 screen-detected cancers treated in a single breast unit. The problems encountered are discussed. There were 87 women with stage Tis or T1 tumours, including 26 women with in situ cancers, four with invasive cancers less than 5 mm in size, and seven with tubular cancers. Sixty-six women were managed with breast-conserving surgery and 36 women underwent localisation biopsy as the sole surgical treatment of the breast. With selection bias for high-grade and lateral tumours, only 2/13 cancers up to 10 mm in size were lymph node positive on axillary clearance. All lymph node positive women received adjuvant therapy. No adjuvant therapy was given in 43 cases, including those with in situ cancer. Thirty-six had extensive intraductal component (EIC). Patient and surgeon choice tends to be a major factor both in type of surgery and adjuvant therapy for screen-detected breast cancer. The optimal treatment for tumours detected by breast cancer screening is debatable and randomised trials on their management need to be expedited.

Full text

PDF
13

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson T. J., Lamb J., Alexander F., Lutz W., Chetty U., Forrest A. P., Kirkpatrick A., Muir B., Roberts M. M., Huggins A. Comparative pathology of prevalent and incident cancers detected by breast screening. Edinburgh Breast Screening Project. Lancet. 1986 Mar 8;1(8480):519–523. doi: 10.1016/s0140-6736(86)90882-2. [DOI] [PubMed] [Google Scholar]
  2. Campbell I. D., Royle G. T., Coddington R., Theaker J., Rubin C. M., Guyer P. B., Taylor I. Technique and results of localization biopsy in a breast screening programme. Br J Surg. 1991 Sep;78(9):1113–1115. doi: 10.1002/bjs.1800780926. [DOI] [PubMed] [Google Scholar]
  3. Fentiman I. S., Mansel R. E. The axilla: not a no-go zone. Lancet. 1991 Jan 26;337(8735):221–223. doi: 10.1016/0140-6736(91)92172-x. [DOI] [PubMed] [Google Scholar]
  4. Fentiman I. S., Matthews P. N., Davison O. W., Millis R. R., Hayward J. L. Survival following local skin recurrence after mastectomy. Br J Surg. 1985 Jan;72(1):14–16. doi: 10.1002/bjs.1800720107. [DOI] [PubMed] [Google Scholar]
  5. Fisher B., Redmond C., Poisson R., Margolese R., Wolmark N., Wickerham L., Fisher E., Deutsch M., Caplan R., Pilch Y. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 1989 Mar 30;320(13):822–828. doi: 10.1056/NEJM198903303201302. [DOI] [PubMed] [Google Scholar]
  6. Fourquet A., Campana F., Zafrani B., Mosseri V., Vielh P., Durand J. C., Vilcoq J. R. Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up. Int J Radiat Oncol Biol Phys. 1989 Oct;17(4):719–725. doi: 10.1016/0360-3016(89)90057-6. [DOI] [PubMed] [Google Scholar]
  7. Guyer P. B. Starting from scratch--some problems with Forrest. Clin Radiol. 1990 Jan;41(1):1–2. doi: 10.1016/s0009-9260(05)80920-1. [DOI] [PubMed] [Google Scholar]
  8. Hamilton C. R., Buchanan R. B. Radiotherapy for ductal carcinoma in situ detected by screening. BMJ. 1990 Jul 28;301(6745):224–225. doi: 10.1136/bmj.301.6745.224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Holland R., Connolly J. L., Gelman R., Mravunac M., Hendriks J. H., Verbeek A. L., Schnitt S. J., Silver B., Boyages J., Harris J. R. The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol. 1990 Jan;8(1):113–118. doi: 10.1200/JCO.1990.8.1.113. [DOI] [PubMed] [Google Scholar]
  10. Holmberg L., Pontén J., Adami H. O. The biology and natural history of breast cancer from the screening perspective. World J Surg. 1989 Jan-Feb;13(1):25–30. doi: 10.1007/BF01671150. [DOI] [PubMed] [Google Scholar]
  11. O'Dwyer P. J. Axillary dissection in primary breast cancer. BMJ. 1991 Feb 16;302(6773):360–361. doi: 10.1136/bmj.302.6773.360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Peeters P. H., Verbeek A. L., Straatman H., Holland R., Hendriks J. H., Mravunac M., Rothengatter C., Van Dijk-Milatz A., Werre J. M. Evaluation of overdiagnosis of breast cancer in screening with mammography: results of the Nijmegen programme. Int J Epidemiol. 1989 Jun;18(2):295–299. doi: 10.1093/ije/18.2.295. [DOI] [PubMed] [Google Scholar]
  13. Roberts M. M., Alexander F. E., Anderson T. J., Chetty U., Donnan P. T., Forrest P., Hepburn W., Huggins A., Kirkpatrick A. E., Lamb J. Edinburgh trial of screening for breast cancer: mortality at seven years. Lancet. 1990 Feb 3;335(8684):241–246. doi: 10.1016/0140-6736(90)90066-e. [DOI] [PubMed] [Google Scholar]
  14. Roberts M. M. Breast screening: time for a rethink? BMJ. 1989 Nov 4;299(6708):1153–1155. doi: 10.1136/bmj.299.6708.1153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Sarrazin D., Lê M. G., Arriagada R., Contesso G., Fontaine F., Spielmann M., Rochard F., Le Chevalier T., Lacour J. Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. Radiother Oncol. 1989 Mar;14(3):177–184. doi: 10.1016/0167-8140(89)90165-5. [DOI] [PubMed] [Google Scholar]
  16. Schnitt S. J., Connolly J. L., Harris J. R., Hellman S., Cohen R. B. Pathologic predictors of early local recurrence in Stage I and II breast cancer treated by primary radiation therapy. Cancer. 1984 Mar 1;53(5):1049–1057. doi: 10.1002/1097-0142(19840301)53:5<1049::aid-cncr2820530506>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  17. Smart C. R., Myers M. H., Gloeckler L. A. Implications from SEER data on breast cancer management. Cancer. 1978 Mar;41(3):787–789. doi: 10.1002/1097-0142(197803)41:3<787::aid-cncr2820410301>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  18. Veronesi U., Banfi A., Del Vecchio M., Saccozzi R., Clemente C., Greco M., Luini A., Marubini E., Muscolino G., Rilke F. Comparison of Halsted mastectomy with quadrantectomy, axillary dissection, and radiotherapy in early breast cancer: long-term results. Eur J Cancer Clin Oncol. 1986 Sep;22(9):1085–1089. doi: 10.1016/0277-5379(86)90011-8. [DOI] [PubMed] [Google Scholar]

Articles from Annals of The Royal College of Surgeons of England are provided here courtesy of The Royal College of Surgeons of England

RESOURCES